CD8A and prostate carcinoma: CD8+ T cell dysfunction within prostate cancer tissues represents a critical mechanism driving the marked impairment of CD8+ T cells’ antitumor activity, and the CD8+ T cell dysfunction is closely linked to disease progression [55,79].